Cargando…

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has undoubtedly become a global crisis. Consequently, discovery and identification of new or known potential drug candidates to solve the health problems caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become an urgent...

Descripción completa

Detalles Bibliográficos
Autor principal:	Rabie, Amgad M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	COVID-19 therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433057/ https://www.ncbi.nlm.nih.gov/pubmed/34870153 http://dx.doi.org/10.1016/j.crphar.2021.100055

Ejemplares similares

Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19
por: Neta, Francisca Idalina, et al.
Publicado: (2021)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

Can NLRP3 inhibitors improve on dexamethasone for the treatment of COVID-19?
por: Hooftman, Alexander, et al.
Publicado: (2021)

Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)

Hypoxia may be a determinative factor in COVID-19 progression
por: Grieb, Pawel, et al.
Publicado: (2021)

Host directed therapies: COVID-19 and beyond
por: Tripathi, Devavrat, et al.
Publicado: (2021)

A research update: Significance of cytokine storm and diaphragm in COVID-19
por: Mittal, Ashwani, et al.
Publicado: (2021)

Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention
por: Rhazouani, Asmaa, et al.
Publicado: (2021)

Recent progress in the development of potential drugs against SARS-CoV-2
por: Chen, Jianmin, et al.
Publicado: (2021)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021)

Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
por: Bajad, Nilesh Gajanan, et al.
Publicado: (2021)

Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL(pro) and M(pro)/ 3CL(pro): molecular docking and simulation studies of three pertinent medicinal plant natural components
por: Verma, Devvret, et al.
Publicado: (2021)

Oral Mucosal Lesions Possibly Associated with COVID-19
Publicado: (2022)

Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2020)

Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom
por: Padmanabhan, Nishita, et al.
Publicado: (2020)

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response
por: Migo, William, et al.
Publicado: (2021)

A Possible Scenario for the Covid-19 Epidemic, Based on the SI(R) Model
por: Rocchi, Ettore, et al.
Publicado: (2020)

A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
por: Hossen, Md. Shafiul, et al.
Publicado: (2020)

A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19
por: Cimolai, Nevio
Publicado: (2021)

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)

COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation
por: Trinchillo, Assunta, et al.
Publicado: (2022)

Building a PPE Monitor Team as Part of a Comprehensive COVID-19 Prevention Strategy
por: Summerlin-Long, Shelley, et al.
Publicado: (2021)

Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID‐19
por: Chandan, Joht Singh, et al.
Publicado: (2021)

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)

The Detrimental Impact of the COVID-19 Pandemic on Major Trauma Outcomes in the Netherlands: A Comprehensive Nationwide Study
por: Driessen, Mitchell L. S., et al.
Publicado: (2022)

The impact of COVID-19 on cancer care in a tertiary hospital in Korea: possible collateral damage to emergency care
por: Yoo, Shin Hye, et al.
Publicado: (2022)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021)

The Association of Cardiovascular Diseases and Diabetes Mellitus with COVID-19 (SARS-CoV-2) and Their Possible Mechanisms
por: Roy, Sourav, et al.
Publicado: (2020)

Repositioned Drugs for COVID-19—the Impact on Multiple Organs
por: Chan, Christina, et al.
Publicado: (2021)

Management of COVID-19 in people with epilepsy: drug considerations
por: Asadi-Pooya, Ali A., et al.
Publicado: (2020)

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
por: Gandhi, Zainab, et al.
Publicado: (2020)

Comprehensive telemedicine solution for remote monitoring of Parkinson’s disease patients with orthostatic hypotension during COVID-19 pandemic
por: Polverino, Paola, et al.
Publicado: (2022)

Ozone (O3) and SARS-CoV-2: Physiological Bases and Their Therapeutic Possibilities According to COVID-19 Evolutionary Stage
por: Fernández-Cuadros, Marcos Edgar, et al.
Publicado: (2020)

Treatment of chronic or relapsing COVID-19 in immunodeficiency
por: Brown, Li-An K., et al.
Publicado: (2022)

MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine
por: Seferoğlu, Meral, et al.
Publicado: (2021)

The Impact of COVID-19 on Cancer Risk and Treatment
por: Jyotsana, Nidhi, et al.
Publicado: (2020)

Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
por: Ahmed, Mukhtar H., et al.
Publicado: (2020)

Developing a pediatric ophthalmology telemedicine program in the COVID-19 crisis
por: Kapoor, Saloni, et al.
Publicado: (2020)

COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment
por: Hapshy, Vera, et al.
Publicado: (2021)

Impact of COVID-19 on Peripheral Arterial Disease Treatment
por: Li, Wenrui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mjlfkc6q4cr2tsmu2riuj0hl0s